Roundup ASEAN Pharma: Novartis’ $256M Singapore Manufacturing Expansion; Filipino ‘Pharma Ecozones’; Korea to Invest in Region?
A roundup of some of the most important recent pharma news from the dynamic ASEAN region, including a big new investment from Novartis in its antibody plant in Singapore, the establishment of ‘pharmaceutical ecozones’ to streamline the drug application process in the Philippines; Vietnam’s journey to attaining WHO Level Four status; and how a lack…